Cargando…
The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis
Aberrant expression of the Spectraplakin Dystonin (DST) has been observed in various cancers, including those of the breast. However, little is known about its role in carcinogenesis. In this report, we demonstrate that Dystonin is a candidate tumour suppressor in breast cancer and provide an underl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934804/ https://www.ncbi.nlm.nih.gov/pubmed/31882643 http://dx.doi.org/10.1038/s41598-019-56296-z |